Dario Amodei 预测癌症、阿尔茨海默病等疾病十年内或被攻克
Anthropic 的 CEO 放话十年内攻克癌症和阿尔茨海默病，正好卡在 IPO 节点前，动机值得琢磨。AI 制药确实在提速，但十年说法业内争议不小。关心 AI 医疗落地和 Anthropic 动向的人可以看看各方怎么看。
Anthropic CEO Dario Amodei 公开表示，癌症、阿尔茨海默病、心脏病和精神疾病有可能在不到十年的时间里成为历史，这一说法基于 AI 加速药物研发与生物医学研究的判断。该言论传出时正值 Anthropic 准备 IPO，时间点引发外界对其动机的讨论。
发布这一观点的人在社交媒体上补充称，尽管时机敏感，他认为这不只是 IPO 前的造势宣传。AI 用于靶点发现、分子设计和临床试验优化的进展，确实在缩短新药研发周期，多家实验室和药企近年也在这一方向持续投入。
需要提醒的是，这目前是 Dario Amodei 的个人预测，而非有具体药物或临床试验数据支撑的结论。十年的时间表在生物医药行业内部存在明显争议，开发者与投资者应区分愿景叙事与已验证的阶段性成果。
Dario Amodei says cancer, Alzheimer's, heart disease and mental illness could be history in less than a decade.
This comes right before Anthropics IPO, but after Fable 5.2 release, I think its true and more than just IPO hype.
This report is categorized under AITOP's "Industry" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows. Key entities and technical topics under continuous tracking include Anthropic, Dario Amodei, AI制药, 生物医药.
Source attribution: curated from kimmonismus (@kimmonismus). Cross-source corroboration: 11 independent sources have covered this development (including Gary Marcus, AI Will, Andrew Curran), confirming industry-wide signal strength.
